317 related articles for article (PubMed ID: 19325231)
1. Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm.
Konda T; Enomoto A; Aritomi S; Niinuma K; Koganei H; Ogawa T; Nitta K
Am J Nephrol; 2009; 30(2):155-61. PubMed ID: 19325231
[TBL] [Abstract][Full Text] [Related]
2. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
[TBL] [Abstract][Full Text] [Related]
3. Effects of an N-type calcium antagonist on angiotensin II-renin feedback.
Aritomi S; Niinuma K; Ogawa T; Konda T; Nitta K
Am J Nephrol; 2011; 33(2):168-75. PubMed ID: 21293118
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.
Aritomi S; Harada E; Sugino K; Nishimura M; Nakamura T; Takahara A
Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):344-52. PubMed ID: 25582553
[TBL] [Abstract][Full Text] [Related]
5. A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker.
Konoshita T; Makino Y; Kimura T; Fujii M; Wakahara S; Arakawa K; Inoki I; Nakamura H; Miyamori I;
J Hypertens; 2010 Oct; 28(10):2156-60. PubMed ID: 20625317
[TBL] [Abstract][Full Text] [Related]
6. Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel.
Shimizu H; Nakagami H; Yasumasa N; Mariana OK; Kyutoku M; Koriyama H; Nakagami F; Shimamura M; Rakugi H; Morishita R
Hypertens Res; 2012 Jan; 35(1):77-81. PubMed ID: 21881574
[TBL] [Abstract][Full Text] [Related]
7. On the top of ARB N/L type Ca channel blocker leads to less elevation of aldosterone.
Konoshita T; Kaeriyama S; Urabe M; Nakaya T; Yamada M; Ichikawa M; Yamamoto K; Sato S; Imagawa M; Fujii M; Makino Y; Zenimaru Y; Wakahara S; Suzuki J; Ishizuka T; Nakamura H;
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27515419
[TBL] [Abstract][Full Text] [Related]
8. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
[TBL] [Abstract][Full Text] [Related]
9. L/N-type calcium channel blocker suppresses reflex aldosterone production induced by antihypertensive action.
Aritomi S; Konda T; Yoshimura M
Heart Vessels; 2012 Jul; 27(4):419-23. PubMed ID: 21989861
[TBL] [Abstract][Full Text] [Related]
10. The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome.
Konda T; Enomoto A; Matsushita J; Takahara A; Moriyama T
Nephron Physiol; 2005; 101(1):p1-13. PubMed ID: 15886499
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats.
Takatsu M; Hattori T; Murase T; Ohtake M; Kato M; Nashima K; Nakashima C; Takahashi K; Ito H; Niinuma K; Aritomi S; Murohara T; Nagata K
J Hypertens; 2012 Sep; 30(9):1845-55. PubMed ID: 22796710
[TBL] [Abstract][Full Text] [Related]
12. Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.
Fan YY; Kohno M; Nakano D; Ohsaki H; Kobori H; Suwarni D; Ohashi N; Hitomi H; Asanuma K; Noma T; Tomino Y; Fujita T; Nishiyama A
J Hypertens; 2010 May; 28(5):1034-43. PubMed ID: 20411599
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.
Hoshide S; Kario K; Ishikawa J; Eguchi K; Shimada K
Hypertens Res; 2005 Dec; 28(12):1003-8. PubMed ID: 16671340
[TBL] [Abstract][Full Text] [Related]
14. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
Morimoto S; Yano Y; Maki K; Iwasaka T
J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
[TBL] [Abstract][Full Text] [Related]
15. Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.
Aritomi S; Niinuma K; Ogawa T; Konda T; Nitta K
Clin Exp Nephrol; 2013 Feb; 17(1):41-50. PubMed ID: 23011292
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of L- and N-type calcium channel blocker on glucose and lipid metabolism and renal function in patients with hypertension and type II diabetes mellitus.
Masuda T; Ogura MN; Moriya T; Takahira N; Matsumoto T; Kutsuna T; Hara M; Aiba N; Noda C; Izumi T
Cardiovasc Ther; 2011 Feb; 29(1):46-53. PubMed ID: 20337636
[TBL] [Abstract][Full Text] [Related]
17. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
Ogura C; Ono K; Miyamoto S; Ikai A; Mitani S; Sugimoto N; Tanaka S; Fujita M
Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
[TBL] [Abstract][Full Text] [Related]
18. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats.
Wagner C; Krämer BK; Hinder M; Kieninger M; Kurtz A
Br J Pharmacol; 1998 Jun; 124(3):579-85. PubMed ID: 9647484
[TBL] [Abstract][Full Text] [Related]
19. Comparison of effects of L/N-type and L-type calcium channel blockers on post-infarct cardiac remodelling in spontaneously hypertensive rats.
Naseratun N; Kobara M; Watanabe Y; Toba H; Nakata T
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1545-1553. PubMed ID: 32323339
[TBL] [Abstract][Full Text] [Related]
20. Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive rats.
Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Nako H; Ogawa H; Kim-Mitsuyama S
J Hypertens; 2010 Jun; 28(6):1321-9. PubMed ID: 20224431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]